Abstract Background: The clinical significance of ER-low tumors compared with ER-0 tumors in HER2-negative breast cancer remains poorly defined, particularly regarding response to neoadjuvant chemotherapy and survival outcomes. This study aimed to compare the clinical characteristics, treatment response, and survival outcomes between ER-low and ER-0 tumors in a real-world multicenter cohort.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile